05 August 2020 - Authored by:Jeanne Fabre

At the end of the Conventional Policy Steering Committee held on 23 July 2020, the French Pharmaceutical Companies Association (Leem) and the French Economic Committee for Health Products (CEPS) agreed to an extension of their Framework Agreement, which is the reference framework for fixing and regulating medicines pricing in France.
The agreement, which would have otherwise expired on 31 July 2020, is now valid until 31 December 2020.